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Getting healthcare in another European country should be straightforward, but it often  
creates problems for both patients and healthcare systems
Patient mobility in the European Union
In September 2006 the European Commission 
launched a consultation on health services, focusing 
mainly on movement of patients across borders.1 The 
longstanding view that health care was the preserve 
of national governments has been rendered unten-
able by the European Court of Justice. Its judgments 
place health services firmly on the European agenda, 
upholding the right of individuals to obtain care 
abroad paid for by their home health system in spe-
cific circumstances (box). We discuss why patients seek 
care abroad, examine the medical and legal issues that 
this raises, and outline some possible responses.
Who seeks care abroad and why?
The number of people who obtain care in another 
European country is very low, accounting for at most 
1% of total health expenditure.4 Although some people 
pay for their own care or are reimbursed by insurance 
policies rather than state systems, this is also likely to be 
a small fraction of total health expenditure. Neverthe-
less, the uneven distribution of movement means that 
in some places, in some circumstances, and for some 
people the implications can be considerable. We have 
identified five broad categories of patient mobility: 
temporary visitors abroad, long term residents retir-
ing to other countries, people living in border areas, 
people who are referred abroad, and people who seek 
treatment abroad themselves. All of these groups may 
experience problems under the current system.
Temporary visitors abroad
Many people now frequently travel abroad. If they 
fall ill in another European Union country they are 
entitled to care in local facilities and to be reimbursed 
by their healthcare funder on presentation of a Euro-
pean Health Insurance Card (which replaced the E111 
form). Yet this often does not happen. Official data on 
claims are barely credible, given the scale of tourist 
movement. Many claims are never processed and, 
even when they are, the money obtained centrally is 
not forwarded to the hospital concerned.5 This dimin-
ishes the incentive to complete the relevant paper-
work, so tourists may not be asked for evidence of 
entitlement to treatment. In some places, providers 
may insist on up-front payment that patients have to 
reclaim from their insurance policy.
Another problem is finding a provider to accept the 
insurance card. Many tourist resorts have established 
networks of guides and taxi drivers who channel tourists 
towards private providers.5 A survey among returning 
German tourists who had experienced illness found that 
only 40% in Austria and 18% in Spain had succeeded in 
using their E111 forms.6 We need to ensure that travel-
lers are better informed about their entitlements and to 
act against those who provide misleading information 
that channels them to private providers.
People retiring to other countries
Although there is a long tradition of people retiring 
to other countries within Europe, most of the move-
ment has been people returning to the country of their 
birth. This is changing as many people from north-
ern Europe retire to southern Europe. When they do 
so, money is transferred from the country they came 
from to the one they are retiring to. These sums are 
substantial, but there can be a lack of transparency in 
determining the amounts.
Some of these immigrants may wish to return home 
to be near families if they need complex care. This is 
not straightforward, however, as they will have trans-
ferred their healthcare entitlement to their new country 
of residence and will require authorisation. The prob-
lems are especially acute for people who divide their 
time between two countries because the bureaucracy 
involved in transferring their entitlements back and 
forth can be extremely daunting, with  additional prob-
lems if they have chronic disorders requiring continuity 
of care.
Traditionally, social care for elderly people in south-
ern Europe has been provided by families, but new 
residents will usually have left their family networks 
behind. This gap is being filled, partially, by northern 
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Box 1 | European legal basis for patient mobility
The legal basis for patient mobility in Europe was established in 1971 through regulation 
1408/712:
•	The E111 scheme enabled people temporarily abroad to get treatment if they became ill, 
with care being paid for by their home funder
•	People were also able to obtain care in another country with prior authorisationfor 
example, someone who had migrated but wanted to return home for treatment of a serious 
illness or someone who wanted to obtain care unavailable at home. Authorisation could 
not be refused if the care otherwise available was subject to “undue delay” 
In 1998 two rulings by the European Court of Justice (the cases of Kohll3 and Decker) relating 
to spectacles and orthodontic treatment, established that individuals could obtain certain 
goods and medical service provided outside hospital and be reimbursed by their health 
funder without getting prior authorisation
A series of cases has since expanded the range of care that can be obtained without 
authorisation and clarified the principles—for example: 
•	Patients  are entitled to treatment for exacerbations of pre-existing illnesses that occur 
while abroad
•	Decisions to authorise treatment abroad must adhere to “international medical opinion” 
rather than national policies
•	Determination of “undue delay” must take account of the individual circumstances 
regardless of a standard waiting time guarantee, such as the English patient’s charter
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European organisations such as the UK’s Age Con-
cern, which is providing support for older people who 
have moved to Spain.7
People in border regions
Europe’s borders often traverse sparsely populated 
areas, dividing communities that share common lan-
guages and cultures and, in some cases, towns and 
villages. Facilities are usually duplicated on either side 
of the border, but increasingly people living in border 
areas can access care in each others’ countries. The 
Euregio Meuse-Rhine region pioneered collaboration 
among organisations in the Netherlands, Germany, 
and Belgium. In another project, French and Catalan 
authorities are jointly building a hospital in a remote 
area near Andorra.8 Payment for care in shared facili-
ties has often used systems based on existing Euro-
pean rules and procedures, but there are increasing 
examples of cross border contracts between statutory 
purchasers and providers, such as those between 
Dutch health insurers and Belgian hospitals.9
Cross border collaboration presents many practical 
problems, ranging from the incompatibility of sirens on 
emergency vehicles to different payment mechanisms.10 
Another is the nationality of children born in a shared 
obstetric unit. The authorities in France and Spain over-
came this by allowing joint citizenship, but nationality 
has proved an obstacle to shared facilities in the divided 
town of Valka (Latvia)/Valga (Estonia).11
Changes in working time and technology are likely to 
increase pressure for centralisation of care, with greater 
use of shared facilities. Experience so far is positive 
and the practical issues seem resolvable if there is the 
will to do so.
People sent abroad by their home systems
Purchasers may establish procedures to allow patients 
to go abroad for care in two situations. The first is to 
overcome a shortage of domestic provision, such as 
Norway’s Medical Treatment Abroad Project, which 
was used to reduce waiting lists for elective surgery.12 
These schemes typically involve large numbers of 
patients but are time limited, allowing authorities to 
develop domestic capacity. The UK government also 
used this approach to challenge what it saw as unre-
sponsive domestic providers in England. Under short 
lived projects, a few patients were referred to Belgium, 
France, and Germany with much publicity. The second 
situation arises when a small country, such as Malta, 
makes an explicit decision to obtain highly specialised 
services abroad because its population is insufficient to 
justify them.13
Most patients referred abroad are positive about 
their treatment, although postoperative management 
is a common concern.14 15 Minor administrative prob-
lems may also arise. Success requires support from all 
stakeholders, especially referring doctors. When the 
schemes are used as a threat to domestic providers, 
health professionals may be unwilling to cooperate, 
with adverse consequences for continuity of care.
People going abroad on their own initiative
Despite their prominence in cases brought before the 
European Court of Justice, few patients travel abroad 
specifically to obtain treatment and, in most cases, their 
treatments lie on the margins of what is funded by their 
healthcare system. Examples include spas, cosmetic 
surgery, and dental treatment.16 Some of the European 
Union’s new member states view their low costs as an 
opportunity to attract patients from western Europe. 
In some cases they have been successful, with dentists 
in border areas of Hungary and Slovenia attracting 
patients from other member states, particularly Austria. 
Elsewhere, however, expected flows have not material-
ised, partly because of competition from countries with 
even lower costs, such as India or South Africa.
Some patients also go abroad for more mainstream 
care because they believe the care is of higher qual-
ity.17 Some of this movement is well establishedfor 
example, from Italy to France— but movement of citi-
zens of the new member states is more recent. The 
volume is not well documented, and official data on 
mobility are clearly a substantial underestimate.
The final group is patients who seek interventions 
that are prohibited at home. Examples include the 
many women travelling from Ireland to the United 
Kingdom to obtain abortions and the smaller number 
of British women going to Spain for late term abor-
tions.18 People seeking treatment for infertility and 
sperm and egg donors are also increasingly moving 
across borders to obtain donor anonymity.
Future challenges
Free movement of people and services within Europe 
makes it impossible to isolate health care behind 
national barriers. Although the numbers so far are 
few, the potential exists for large numbers of people 
to assert their right to obtain care abroad. The cru-
cial issue is who pays and how much. When prior 
BMJ | 27 JANUARY 2007 | VolUMe 334      189
H
Ei
kk
i S
au
kk
O
M
aa
/R
EX
When people from northern Europe retire to southern Europe their healthcare entitlement is 
transferred to their new country
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authorisation is required, the patient’s home health 
system pays the established price in the system provid-
ing treatment. This could result in providers in new 
member states, such as Poland, facing a very large bill 
should a patient seek treatment in, say, Germany. 
When prior authorisation is not required, the situa-
tion is complex. The amount reimbursed depends on 
factors such as the relative prices in the two countries 
concerned and levels of copayments. In essence, the 
determining factor is whether the cost to the patient 
is seen as a barrier to free movement. However, this 
creates considerable uncertainty for the patient.
Access to medical information is a common 
 problem. Several countries have implemented elec-
tronic patient record systems but, inevitably, these 
are incompatible with each other. For example, some 
countries have decided to incorporate electronic 
patient data into the new European Health Insurance 
Card but some, such as Spain and Portugal, use mag-
netic strips and others, such as Austria, France, and 
Germany, use electronic chips.
Looking ahead, it is important to recognise the 
potential consequences of European competition law 
on health services.12 Rulings in the education and 
other sectors suggest that national health services, in 
which the money allotted to a service is not a direct 
compensation for the service provided to the patient, 
lie outside its provisions. However, the creation of a 
market within national systems, as in England, could 
open the health sector to competition law. This would 
allow prospective market entrants, such as multina-
tional corporations, to challenge existing NHS con-
tracts, potentially destabilising even further existing 
patterns of provision and making coordinated recon-
figurations more difficult.
The European Commission has called for legal cer-
tainty about patient mobility. In some cases this will be 
relatively straightforward, simply requiring clarification 
of how existing legal principles apply to health care, 
such as those on liability in the event of problems with 
cross border contracts. In others it will require reaching 
a political consensus on the role of the market in the 
provision of health care. Within Europe there is broad 
agreement that market mechanisms should be man-
aged to ensure that citizens have equitable access to a 
balanced package of health services. 
One way forward is for legal reforms to build on 
the current regulation, clarifying areas it left unre-
solved. Each member state would have to develop 
mechanisms to determine what it considered “undue 
delay” and have systems in place to ensure minimum 
standards for safety and quality among its provid-
ers. It would also mean that Europe’s citizens would 
have to accept that they would need to obtain prior 
authorisation if they wanted to go abroad specifically 
to receive certain types of treatment, but at least the 
process would be more transparent than at present.
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SUMMARY PoINtS
Free movement of people within Europe makes cross border 
care important 
Sharing facilities in border areas has many benefits but 
presents practical problems 
The special needs of people retiring to other European 
countries are not adequately met
A compromise is needed to ensure access to care without 
damaging the sustainability and integrity of national 
health systems
Within Europe there 
is broad agreement 
that market 
mechanisms should 
be managed to 
ensure that citizens 
have equitable 
access to a balanced 
package of health 
services
